Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Empowernd

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Not Yet Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07898592Not ApplicableNot Yet Recruiting

Single Session Support for Parents of Children With Neurodevelopmental Disabilities Struggling With Anxious Avoidance

NCT05803278Not ApplicableCompletedPrimary

Online Screening and Empowerment Program for Children With SLD

Showing all 2 trials

Research Network

Common Treatments

  • Empowernd1
  • Online Enhancement Training1

Active Sponsors

  • IRCCS Burlo Garofolo1
  • Boston University Charles River Campus1

Top Investigators

Related Conditions

  • Intellectual Disability1
  • Communication Disorders1
  • Motor Tic Disorders1
  • Neurodevelopmental Disorders1
  • Fragile X Syndrome1

Activity Timeline